跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 167 条关于
“D1/D5”
全部
167
临床试验
103
药物
30
机构
0
资讯
34
去年
Tavapadon Shows Promise in Phase 3 Trials for Parkinson's Disease with Improved Motor Function and Safety Profile
去年
Annovis Bio's Buntanetap Enters Phase 3 for Early Alzheimer's, AbbVie's Tavapadon Shows Promise in Parkinson's
5个月前
Tavapadon Shows Promise for Parkinson's Disease Treatment in Phase 3 Trials
去年
AbbVie's Tavapadon Shows Positive Results in Phase 3 Parkinson's Disease Trial
去年
AbbVie's Tavapadon Shows Positive Phase 3 Results for Parkinson's Disease
6个月前
Emalex Biosciences Initiates Expanded Access Program for Novel Tourette Syndrome Therapy Ecopipam
8个月前
Two Novel Parkinson's Therapies Advance to Late-Stage Clinical Trials
9个月前
Circle Pharma Nominates CID-165 as Second Oncology Program Targeting Cyclin D1-Driven Cancers
去年
Radiogenomics Predicts and Characterizes Pneumonitis in Stage III NSCLC
去年
IQVIA Gains CDSCO Panel Approval for Phase III Lumateperone Trial in Pediatric Bipolar Depression
第 1 页,共 4 页
上一页
下一页